State Street
CAI

State Street’s Caris Life Sciences CAI Stock Holding History

State Street’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.7M Buy
1,217,548
+232,595
+24% +$4.16M ﹤0.01% 2313
2026
Q1 		$17.6M Buy
984,953
+724,308
+278% +$15.8M ﹤0.01% 2302
2025
Q4 		$7.03M Buy
260,645
+105,305
+68% +$2.97M ﹤0.01% 2826
2025
Q3 		$4.7M Buy
+155,340
New +$4.95M ﹤0.01% 3015

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street's CAI Position: Q2 2026 in Review

State Street increased its Caris Life Sciences (CAI) stake by 24% in Q2 2026, buying an estimated $4.16M and bringing the position to 1,217,548 shares worth $21.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2313.

State Street first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • State Street held 1,217,548 shares of Caris Life Sciences worth $21.7M as of Q2 2026.
  • State Street bought 232,595 Caris Life Sciences shares in Q2 2026, an estimated $4.16M.
  • Caris Life Sciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2313 holding.
  • State Street first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.